WITH THE TREND RISING AT AN ALARMING RATE. YEAH, AND BLAKE, THOSE NUMBERS RISING SO QUICKLY THAT NOW NISSANS ARE THE SECOND MOST COMMONLY STOLEN VEHICLE IN THE CITY. ACCORDING TO COURT RECORDS, IT’S ...

Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...

Researchers showed that an experimental therapy indirectly converted suppressive immune cells into tumor-fighting cells. This ...

New study reveals metabolic remodeling as an early event in diastolic dysfunction Restrictive cardiomyopathy (RCM) caused by ...

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.

Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies and key biomarkers identifiedAT-108 combines the advantages of an off-the-she ...

The immune cells are a key part of the body that keep humans healthy. But that also means when the cells age, the body grows ...

Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard's lead asset AT-108 into Phase 1 clinical development -- AT-108 is a transformative immunotherapy that ...

Early Career and Entrepreneurial Growth Jordan’s success did not start with rich parents, a trust fund, or an extensive ...